Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue MSA Safety Q1 2026 Earnings EPS Surprises Positively as Industrial Demand Holds Steady CVM Q4 2024 Earnings Narrowing Losses with a 19 EPS Surprise LAC Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress at Thacker Pass Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges Under Armour Q1 2026 Earnings A Mixed Quarter with EPS Miss but Stock Gains